Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4343

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 70518-4343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (4cd7b19c D80f 4c80 8795 F4c9566ab59a 01)

Chemical structure of bupropion hydrochloride, showing a chlorophenyl ring connected to a ketone group and tert-butyl moiety, with an associated hydrochloride (HCl) group.*

FDA Label Image

Remedy_label (Remedy Label)

Label for bupropion hydrochloride extended-release tablets, 300 mg strength, in a quantity of 30 blisters. The label includes storage instructions, manufacturer Rising Pharma, Inc., and repackager RemedyRepack Inc. It notes the tablets are round and pink with imprint 189 and provides a warning against use with Zyban or other bupropion hydrochloride medicines.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.